Obesity Mediates Response to Antiarrhythmic Drugs in A-Fib
Reduced response to sodium versus potassium channel blocker AADs seen in obese patients, mice
Read MoreDec 2, 2019
Reduced response to sodium versus potassium channel blocker AADs seen in obese patients, mice
Read MoreDec 2, 2019
48.1 percent of baby boomers screened for HCV, varying from 19.8 to 71.3 percent by practice
Read MoreDec 2, 2019
Most lethal method is firearms, with 89.6 percent of suicidal acts with firearms resulting in death
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in Allergy for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Asthma Exacerbations May Worsen Pregnancy Outcomes WEDNESDAY, Nov. […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Outcomes Poorer With New U.S. Donor Heart Allocation […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for Working-Age […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Practice Organization Not Tied to Family Physician […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Continuous PPI Use May Increase Risk for Acute […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Continuous PPI Use May Increase Risk for […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in Neurology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Three Meds Equal as Second-Line Therapy for Status […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in Nursing for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Antimicrobial Resistance Patterns Examined for Adult, Peds HAIs […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Fewer Interval Cancers Diagnosed With […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Fewer Interval Cancers Diagnosed With Supplemental […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for Working-Age […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in Orthopedics for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. U.S. Life Expectancy Dropped Since 2014 for Working-Age […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Three Meds Equal as Second-Line Therapy for Status […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Practice Organization Not Tied to Family Physician Burnout […]
Read MoreDec 2, 2019
Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for November 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Object-Related Aspiration Deaths Decreased Among Children WEDNESDAY, Nov. […]
Read More